344 related articles for article (PubMed ID: 31986084)
1. Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation.
Schwabkey ZI; Jenq RR
Annu Rev Med; 2020 Jan; 71():137-148. PubMed ID: 31986084
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.
Shono Y; van den Brink MRM
Nat Rev Cancer; 2018 May; 18(5):283-295. PubMed ID: 29449660
[TBL] [Abstract][Full Text] [Related]
3. [Intestinal microbiota and allogeneic stem cell transplantation].
Dougé A; Bay JO; Ravinet A; Scanzi J
Bull Cancer; 2020 Jan; 107(1):72-83. PubMed ID: 31582175
[TBL] [Abstract][Full Text] [Related]
4. Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation.
DeFilipp Z; Hohmann E; Jenq RR; Chen YB
Biol Blood Marrow Transplant; 2019 Jan; 25(1):e17-e22. PubMed ID: 30408565
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease.
van Lier YF; Vos J; Blom B; Hazenberg MD
Gut Microbes; 2023; 15(1):2178805. PubMed ID: 36794370
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota and acute graft-versus-host disease.
Yoshioka K; Kakihana K; Doki N; Ohashi K
Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
[TBL] [Abstract][Full Text] [Related]
8. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
9. Fecal Microbiota Transplantation for Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Expanding the Horizon into Pediatrics.
Gray AN; DeFilipp Z
Transplant Cell Ther; 2023 Aug; 29(8):484-491. PubMed ID: 37169290
[TBL] [Abstract][Full Text] [Related]
10. Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation.
Ciernikova S; Kasperova B; Drgona L; Smolkova B; Stevurkova V; Mego M
Blood Rev; 2021 Jul; 48():100790. PubMed ID: 33573867
[TBL] [Abstract][Full Text] [Related]
11. Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation.
Raghunathan VM; Sheng I; Lim SH
J Transl Med; 2016 Dec; 14(1):335. PubMed ID: 27912759
[TBL] [Abstract][Full Text] [Related]
12. Emerging Influence of the Intestinal Microbiota during Allogeneic Hematopoietic Cell Transplantation: Control the Gut and the Body Will Follow.
Docampo MD; Auletta JJ; Jenq RR
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1360-6. PubMed ID: 25708215
[TBL] [Abstract][Full Text] [Related]
13. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
Kumari R; Palaniyandi S; Hildebrandt GC
Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
[TBL] [Abstract][Full Text] [Related]
14. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.
Holler E; Butzhammer P; Schmid K; Hundsrucker C; Koestler J; Peter K; Zhu W; Sporrer D; Hehlgans T; Kreutz M; Holler B; Wolff D; Edinger M; Andreesen R; Levine JE; Ferrara JL; Gessner A; Spang R; Oefner PJ
Biol Blood Marrow Transplant; 2014 May; 20(5):640-5. PubMed ID: 24492144
[TBL] [Abstract][Full Text] [Related]
15. The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation.
Henig I; Yehudai-Ofir D; Zuckerman T
Haematologica; 2021 Apr; 106(4):933-946. PubMed ID: 33241674
[TBL] [Abstract][Full Text] [Related]
16. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
Staffas A; Burgos da Silva M; van den Brink MR
Blood; 2017 Feb; 129(8):927-933. PubMed ID: 27940475
[TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.
Goeser F; Sifft B; Stein-Thoeringer C; Farowski F; Strassburg CP; Brossart P; Higgins PG; Scheid C; Wolf D; Holderried TAW; Vehreschild MJGT; Cruz Aguilar MR
Eur J Haematol; 2021 Aug; 107(2):229-245. PubMed ID: 33934412
[TBL] [Abstract][Full Text] [Related]
18. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation.
Gu Z; Xiong Q; Wang L; Wang L; Li F; Hou C; Dou L; Zhu B; Liu D
Cancer; 2022 Apr; 128(7):1402-1410. PubMed ID: 35077579
[TBL] [Abstract][Full Text] [Related]
19. Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward.
Habibi S; Rashidi A
Gut Microbes; 2023; 15(1):2229567. PubMed ID: 37382423
[TBL] [Abstract][Full Text] [Related]
20. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
Parco S; Benericetti G; Vascotto F; Palmisciano G
Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
